Go to Page # Page of 23

Preclinical Efficacy Testing Standardization and the Predictive Validity of 3D Models

 Jason Ekert
  26th-Oct-2017
Description: Background on pharma industry and success rate What are the greatest opportunities and challenges in adoption of more predictive 3D models? What key components should be considered when developing a predictive 3D model?
Views: 481
Domain: Medical
Category: Biotech/Pharma
Contributing Organization: Hanson Wade
 ‐ More of their Presentations
Maxims of Tech: Rules of Engagement for a Fast Changing Environment
Contents:
Determining the Predictive Validity of 3D Models &
Achieving Standardization for Preclinical Efficacy
Testing
August 28 2017
Jason Ekert, Head of Complex In Vitro Models
Platform Technology and Sciences
GlaxoSmithKline (GSK)

Overview
– Background on pharma industry and success rate
– What are the greatest opportunities and challenges in adoption of more
predictive 3D models?
... See more

Recent Presentations

Jeff Olsen MD
15 December, 2017
...
14 December, 2017
...
13 December, 2017